Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-120365·Coastlands Capital LP
Schedule 13G ownership disclosure
XILIO THERAPEUTICS INC
Common Stock, par value $0.0001 per share · CUSIP: 98422T100
Event date: 2025-12-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Coastlands Capital LP
Shares: 5,346,069.00 · Class: 9.99%
- Coastlands Capital Partners LP
Shares: 5,346,069.00 · Class: 9.99%
- Coastlands Capital GP LLC
Shares: 5,346,069.00 · Class: 9.99%
- Coastlands Capital LLC
Shares: 5,346,069.00 · Class: 9.99%
- Matthew D. Perry
Shares: 5,346,069.00 · Class: 9.99%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-120365
- Form type
- SCHEDULE 13G
- Filer
- Coastlands Capital LP
- CIK
- CIK 2068530
- Filed
- Dec 11, 2025
- Reporting period
- Dec 04, 2025
- Description
- Schedule 13G beneficial ownership